Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : NFX Bio
Deal Size : $6.5 million
Deal Type : Financing
TwoStep Therapeutics Launches to Advance Targeting Platform for Solid Tumors
Details : The proceeds from the financing will be used to advance TwoStep’s therapeutic pipeline of solid tumor-targeting therapies, with an initial focus on targeted cytotoxic drug delivery and immunotherapy.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
June 25, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : NFX Bio
Deal Size : $6.5 million
Deal Type : Financing